$GL

Darden James Matthew sold $9.1M of GL

Darden James Matthew (Co-Chairman & CEO) sold 50,000 shares of GLOBE LIFE INC. (GL) at an average of $182.43 ($182.43–$183.36, $9.12M total) across 2 trades on 2026-07-31.

Original reporting
SEC EDGAR · Darden James Matthew
Published Aug 3, 2026, 9:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GL
Neutral
high confidence
Mentioned
$GL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLNeutralLow
01

Why it matters

The newest disclosed fact is the sale of ~50,000 shares for about $9.12M at $182.43 average, with no pre-arranged 10b5-1 plan noted. This can slightly pressure sentiment, but it does not provide new guidance, earnings, or regulatory developments.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is not a standalone fundamental catalyst for GL.

03

What to watch

The article does not state the insider’s total compensation, tax liability, or broader selling history, so interpreting motive from one sale is uncertain.

Relevance 6/10Novelty 3/10Timing: filed Aug 3, covering trades on Jul 31

Background

The article is an SEC Form 4 insider transaction disclosure for Globe Life (GL) by its Co-Chairman and CEO, Darden James Matthew.

Company-level read

Ticker impact

$GLNeutralHigh confidence
Context

SEC Form 4 shows Darden James Matthew sold about 50,000 shares of Globe Life (GL) for roughly $9.12M at $182.43 average.

Expected impact

Likely limited near-term price impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing discloses the sale size, price range, and that it was not under a pre-arranged 10b5-1 plan, but it does not include new operating, financial, or regulatory information about GL.

Market effects

Minimal; insider sale in a single insurer does not materially reset sector fundamentals.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity events (taxes, diversification) and may not signal deterioration in business prospects.

Key entities

  • Globe Life Inc.

    US-listed company whose insider sale is disclosed via Form 4.

  • Darden James Matthew

    Co-Chairman and CEO who sold shares in open-market transactions.

Related articles

$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with